Sign In
Buy CME
$237.38
-7.73 (-3.15%)
At Close: Jul 21, 2026
My Dividend Growth Portfolio - Final 2022 Recap
02:44am, Monday, 02'nd Jan 2023
2022 was another fantastic year for dividend growth, with my income increasing by over 13%. I recount every sale made during the year and the replacement purchases.
2023 Dividend Growth Portfolio Review And Look Ahead
06:30am, Sunday, 01'st Jan 2023 Seeking Alpha
I review my current holdings and sectors in the portfolio and how it has changed over the years. See my income projections for 2023 and potential pitfalls.
2023 Dividend Growth Portfolio Review And Look Ahead
01:30am, Sunday, 01'st Jan 2023
Review of the current holdings and sectors in the portfolio, and how it has changed over the years. Income projections for 2023, and potential pitfalls.
CME Group: One Of The Best High-Yielders On The Market
10:56am, Wednesday, 28'th Dec 2022
CME Group is my worst-performing dividend stock, as I'm down 17%. However, I'm even more bullish now as the company offers tremendous value at these prices.
Dividend Champion, Contender, And Challenger Highlights: Week Of December 25
06:06am, Sunday, 25'th Dec 2022 Seeking Alpha
Weekly summary of dividend activity for Dividend Champions, Contenders, Challengers. Click here to read companies with upcoming ex-dividend dates.
Why Should You Stay Invested in CME Group (CME) Stock Now?
03:20pm, Friday, 23'rd Dec 2022 Zacks Investment Research
CME Group's (CME) global presence, compelling product portfolio, and focus on over-the-counter clearing services and effective capital deployment poise it well for growth.
Why Should You Stay Invested in CME Group (CME) Stock Now?
12:02pm, Friday, 23'rd Dec 2022
CME Group's (CME) global presence, compelling product portfolio, and focus on over-the-counter clearing services and effective capital deployment poise it well for growth.
Are Options Traders Betting on a Big Move in CME Group (CME) Stock?
03:04pm, Wednesday, 21'st Dec 2022 Zacks Investment Research
Investors need to pay close attention to CME Group (CME) stock based on the movements in the options market lately.
2 Dividend Stocks That Treat Their Investors With Something Special Each Year
12:38pm, Monday, 19'th Dec 2022 The Motley Fool
These dividend stocks give their investors an extra special payment each year.
Building A $100,000 Market-Crushing Dividend Portfolio
12:30pm, Monday, 19'th Dec 2022 Seeking Alpha
In this article, I start by explaining the theoretical background behind the success of dividend (growth) investing. Read more here.
2 Dividend Stocks That Treat Their Investors With Something Special Each Year
07:38am, Monday, 19'th Dec 2022
These dividend stocks give their investors an extra special payment each year.
Why Tomorrow Could Be a Huge Day for the Stock Market
12:10pm, Monday, 12'th Dec 2022 The Motley Fool
New inflation data is due out in the morning, and the Federal Reserve's final meeting of the year kicks off.
The Zacks Analyst Blog Highlights Analog Devices, The Southern Company, Canadian Pacific Railway, CME Group and UBS
11:50am, Thursday, 08'th Dec 2022 Zacks Investment Research
Analog Devices, The Southern Company, Canadian Pacific Railway, CME Group and UBS are included in this Analyst Blog.
Top Stock Reports for Analog Devices, Southern Company & Canadian Pacific Railway
09:42pm, Wednesday, 07'th Dec 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including Analog Devices, Inc. (ADI), Southern Company (SO) and Canadian Pacific Railway Limited (CP).
Cramer Recommends Avoiding This Trump-Linked SPAC: Here's Why
01:42pm, Tuesday, 06'th Dec 2022 Benzinga
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Symbotic Inc (NASDAQ: SYM) is a "money-losing SPAC. We’re not recommending any money losers."
"Everybody’s in this darn business," Cramer
